Zacks Investment Research on MSN3d
Down -9.23% in 4 Weeks, Here's Why Veru (VERU) Looks Ripe for a Turnaround
A downtrend has been apparent in Veru Inc. (VERU) lately with too much selling pressure. The stock has declined 9.2% over the ...
Nasdaq20d
Insider Purchase: Director at $VERU Buys 95,279 Shares
$VERU insiders have traded $VERU stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales. Here’s a ...
ETF Daily News22d
Veru Inc. (NASDAQ:VERU) Short Interest Up 14.3% in January
Gladstone Institutional Advisory LLC increased its stake in Veru by 34.2% during the 3rd quarter. Gladstone Institutional Advisory LLC now owns 56,876 shares of the company’s stock valued at $ ...
Wall Street Journal24d
Veru Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Seeking Alpha24d
Veru targets Phase 3 enobosarm trials following promising Phase 2b results in obesity treatment
Veru has transitioned into a late clinical-stage biopharmaceutical company, concentrating on cardiometabolic and inflammatory diseases. CEO Mitchell Steiner highlighted enobosarm and sabizabulin ...
Morningstar6d
Veru Inc
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...